BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
Rhea-AI Summary
BeautyHealth (NASDAQ: SKIN) appointed Philippe Schaison, PharmaD to its Board of Directors, effective October 30, 2025. Schaison brings over 20 years of leadership across global aesthetics, biotech, and consumer health, including roles as CEO NA of Syneron Candela and President of Allergan Aesthetics, and current CEO of Soltégo, Inc.
He will join the Compensation and Nominating & Corporate Governance Committees. Following the appointment, the Board will total eight directors. The company said Schaison’s experience should help expand Hydrafacial’s global reach and accelerate category growth.
Positive
- Appointed Philippe Schaison effective Oct 30, 2025
- Adds 20+ years in aesthetics, biotech, and consumer health
- Schaison currently serves as CEO of Soltégo, Inc.
- Joins Compensation and Nominating & Corporate Governance Committees
- Board size increases to eight directors
Negative
- None.
News Market Reaction
On the day this news was published, SKIN declined 4.20%, reflecting a moderate negative market reaction. Argus tracked a peak move of +7.6% during that session. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $8M from the company's valuation, bringing the market cap to $174M at that time.
Data tracked by StockTitan Argus on the day of publication.
Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors
LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025.
Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L’Oréal. Today, Dr. Schaison serves as Chairman of the Board of Raziel Therapeutics Ltd., an Israeli-based biotechnology company, and sits on a number of other biomedical company boards including AIVITA Biomedical, Inc., Dyve Biosciences, Inc., and miraDry, Inc. Dr. Schaison earned an M.B.A. from Hautes Etudes Commerciales in Paris, and a Doctorate in Pharmacy from the Université Paris V René Descartes.
BeautyHealth Executive Chairman Brent Saunders said: “Philippe’s experience scaling global beauty and aesthetics businesses, coupled with his proven ability to drive innovation and profitability, will bring invaluable perspective to the BeautyHealth Board. His deep expertise will help the Company unlock the full potential of the dynamic Hydrafacial brand, elevate our global reach, and accelerate category growth.”
Dr. Schaison fills an open seat on the BeautyHealth Board and will join the Compensation and Nominating & Corporate Governance Committees. Following the appointment, BeautyHealth’s Board will be comprised of eight directors.
About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn.
Contacts:
Investors: IR@beautyhealth.com
Media: press@beautyhealth.com
Source: BeautyHealth
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e88819a-f590-4e51-a7fe-66872a55b5ef
FAQ
Who did BeautyHealth (SKIN) appoint to its board on November 3, 2025?
What roles will Philippe Schaison hold on the BeautyHealth board (SKIN)?
How many directors will BeautyHealth (SKIN) have after the appointment?
What relevant experience does Philippe Schaison bring to BeautyHealth (SKIN)?
What is Philippe Schaison’s current executive position referenced in the announcement?
